Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
The importance of low-density lipoprotein (LDL) control in the management of patients at high risk of cardiovascular events is unquestionable. The major statin trials have shown that the benefits of LDL lowering extend throughout the range of risk and the range of serum cholesterol, and have indicat...
Guardat en:
| Publicat a: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59646/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806766/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-1-008 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|